Scimago Lab
powered by Scopus
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST


eISSN: 1643-3750

Get your full text copy in PDF

IL-6 and sIL-6R concentration in the cerebrospinal fluid and serum of MS patients

Zbigniew Stelmasiak, Maria KozioĊ‚-Montewka, Beata Dobosz, Konrad Rejdak

Med Sci Monit 2001; 7(5): CR914-918

ID: 509067

Background:     The aim of this study was to determine the concentration of cytokine IL-6 in correlation with its soluble receptor sIL-6R in the serum and CSF of MS patients.
Material/Methods:     The study group consisted of 52 MS patients in clinical stage 2-7 according to the Kurtzke Scale (mean 3.6&plusm;1.8); the disease duration ranged from 2 to 22 years. The levels of interleukin-6 and sIL-6R in serum and CSF were determined using commercial ELISA kits.
Results:     An significant increase of IL-6 (p=0.03) was found in the serum of MS patients (12.1&plusm;1.8 pg/ml) in comparison to the control group (6.6&plusm;4.5 pg/ml). The concentration of IL-6 in the CSF of MS patients was 13.4&plum;1.77 pg/ml, and in the majority of patients was higher than in the serum. The highest mean IL-6 concentrations in serum and CSF were found in patients with a longer disease duration, although the differences were not statistically significant. We found some degree of dependence between the serum IL-6 concentration and the level of disability on the Kurtzke scale. The concentrations of sIL-6R in serum (34.0&plusm;39.0 pg/ml) and cerebrospinal fluid (1.4&plusm;3.3 pg/ml) were significantly higher in MS patients than in the controls.
Conclusions:     IL-6 and its soluble receptors are involved in a complex immunological reaction that is characteristic for MS. However, the significant differences in the results obtained here from those reported in other studies make it rather unlikely that IL-6 and its receptors could be used as surrogate markers of MS activity.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree